mecysteine has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, BJ; Farias, NBS; Figueiredo, CA; Lemos, LIC; Lima, JPMS; Medeiros, KCP; Medeiros, MA; Pedrosa, LFC; Silva, FS; Teixeira, TO | 1 |
1 other study(ies) available for mecysteine and Alloxan Diabetes
| Article | Year |
|---|---|
S-methyl cysteine sulfoxide mitigates histopathological damage, alleviate oxidative stress and promotes immunomodulation in diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Cysteine; Diabetes Mellitus, Experimental; Immunomodulation; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Sulfoxides | 2021 |